nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CHRM5—Monoamine GPCRs—DRD4—conduct disorder	0.0436	0.0436	CbGpPWpGaD
Oxybutynin—CHRM5—Amine ligand-binding receptors—DRD4—conduct disorder	0.0366	0.0366	CbGpPWpGaD
Oxybutynin—CHRM1—Monoamine GPCRs—DRD4—conduct disorder	0.0307	0.0307	CbGpPWpGaD
Oxybutynin—CHRM3—Monoamine GPCRs—DRD4—conduct disorder	0.0306	0.0306	CbGpPWpGaD
Oxybutynin—CHRM2—Monoamine GPCRs—DRD4—conduct disorder	0.0303	0.0303	CbGpPWpGaD
Oxybutynin—CHRM5—Monoamine GPCRs—HTR2A—conduct disorder	0.0284	0.0284	CbGpPWpGaD
Oxybutynin—CHRM1—Amine ligand-binding receptors—DRD4—conduct disorder	0.0258	0.0258	CbGpPWpGaD
Oxybutynin—CHRM3—Amine ligand-binding receptors—DRD4—conduct disorder	0.0257	0.0257	CbGpPWpGaD
Oxybutynin—CHRM2—Amine ligand-binding receptors—DRD4—conduct disorder	0.0255	0.0255	CbGpPWpGaD
Oxybutynin—CHRM5—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0239	0.0239	CbGpPWpGaD
Oxybutynin—CHRM1—Monoamine GPCRs—HTR2A—conduct disorder	0.02	0.02	CbGpPWpGaD
Oxybutynin—CHRM3—Monoamine GPCRs—HTR2A—conduct disorder	0.02	0.02	CbGpPWpGaD
Oxybutynin—CHRM2—Monoamine GPCRs—HTR2A—conduct disorder	0.0198	0.0198	CbGpPWpGaD
Oxybutynin—CHRM5—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0187	0.0187	CbGpPWpGaD
Oxybutynin—CHRM1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0168	0.0168	CbGpPWpGaD
Oxybutynin—CHRM3—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0168	0.0168	CbGpPWpGaD
Oxybutynin—CHRM2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0166	0.0166	CbGpPWpGaD
Oxybutynin—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.0162	0.0162	CbGpPWpGaD
Oxybutynin—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0157	0.0157	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Other—DRD4—conduct disorder	0.0136	0.0136	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Other—DRD4—conduct disorder	0.0135	0.0135	CbGpPWpGaD
Oxybutynin—CHRM1—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0131	0.0131	CbGpPWpGaD
Oxybutynin—CHRM3—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0131	0.0131	CbGpPWpGaD
Oxybutynin—CHRM2—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.013	0.013	CbGpPWpGaD
Oxybutynin—CHRM5—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0129	0.0129	CbGpPWpGaD
Oxybutynin—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0103	0.0103	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—CGA—conduct disorder	0.0098	0.0098	CbGpPWpGaD
Oxybutynin—CHRM2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0093	0.0093	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00906	0.00906	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00903	0.00903	CbGpPWpGaD
Oxybutynin—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00896	0.00896	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00894	0.00894	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Other—HTR2A—conduct disorder	0.00886	0.00886	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Other—HTR2A—conduct disorder	0.00878	0.00878	CbGpPWpGaD
Oxybutynin—CHRM5—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00841	0.00841	CbGpPWpGaD
Oxybutynin—CHRM1—Circadian rythm related genes—SLC6A4—conduct disorder	0.00769	0.00769	CbGpPWpGaD
Oxybutynin—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00736	0.00736	CbGpPWpGaD
Oxybutynin—CHRM1—Circadian rythm related genes—DRD4—conduct disorder	0.00723	0.00723	CbGpPWpGaD
Oxybutynin—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00721	0.00721	CbGpPWpGaD
Oxybutynin—CHRM5—G alpha (q) signalling events—HTR2A—conduct disorder	0.0071	0.0071	CbGpPWpGaD
Oxybutynin—CHRM2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.007	0.007	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—CGA—conduct disorder	0.0069	0.0069	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—CGA—conduct disorder	0.00688	0.00688	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.00681	0.00681	CbGpPWpGaD
Oxybutynin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00635	0.00635	CbGpPWpGaD
Oxybutynin—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.0063	0.0063	CbGpPWpGaD
Oxybutynin—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00592	0.00592	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0059	0.0059	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00585	0.00585	CbGpPWpGaD
Oxybutynin—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.0057	0.0057	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—CGA—conduct disorder	0.00554	0.00554	CbGpPWpGaD
Oxybutynin—CYP3A5—Biological oxidations—COMT—conduct disorder	0.00553	0.00553	CbGpPWpGaD
Oxybutynin—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.00549	0.00549	CbGpPWpGaD
Oxybutynin—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00549	0.00549	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—DRD4—conduct disorder	0.00549	0.00549	CbGpPWpGaD
Oxybutynin—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.00546	0.00546	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00507	0.00507	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00506	0.00506	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—CGA—conduct disorder	0.00503	0.00503	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00501	0.00501	CbGpPWpGaD
Oxybutynin—CHRM1—G alpha (q) signalling events—HTR2A—conduct disorder	0.005	0.005	CbGpPWpGaD
Oxybutynin—CHRM3—G alpha (q) signalling events—HTR2A—conduct disorder	0.00498	0.00498	CbGpPWpGaD
Oxybutynin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00481	0.00481	CbGpPWpGaD
Oxybutynin—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00479	0.00479	CbGpPWpGaD
Oxybutynin—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00476	0.00476	CbGpPWpGaD
Oxybutynin—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00473	0.00473	CbGpPWpGaD
Oxybutynin—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.0047	0.0047	CbGpPWpGaD
Oxybutynin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00447	0.00447	CbGpPWpGaD
Oxybutynin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00446	0.00446	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00408	0.00408	CbGpPWpGaD
Oxybutynin—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00393	0.00393	CbGpPWpGaD
Oxybutynin—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00391	0.00391	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—CGA—conduct disorder	0.0039	0.0039	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—CGA—conduct disorder	0.00389	0.00389	CbGpPWpGaD
Oxybutynin—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00388	0.00388	CbGpPWpGaD
Oxybutynin—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00386	0.00386	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—DRD4—conduct disorder	0.00386	0.00386	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00385	0.00385	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—DRD4—conduct disorder	0.00385	0.00385	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.00385	0.00385	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00381	0.00381	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.00381	0.00381	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—HTR2A—conduct disorder	0.00358	0.00358	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—CGA—conduct disorder	0.00354	0.00354	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—CGA—conduct disorder	0.00353	0.00353	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.00349	0.00349	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00331	0.00331	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.0033	0.0033	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00327	0.00327	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—DRD4—conduct disorder	0.0031	0.0031	CbGpPWpGaD
Oxybutynin—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00302	0.00302	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CGA—conduct disorder	0.00297	0.00297	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—DRD4—conduct disorder	0.00282	0.00282	CbGpPWpGaD
Oxybutynin—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00257	0.00257	CbGpPWpGaD
Oxybutynin—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00255	0.00255	CbGpPWpGaD
Oxybutynin—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00254	0.00254	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	0.00252	0.00252	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	0.00251	0.00251	CbGpPWpGaD
Oxybutynin—CHRM1—Circadian rythm related genes—EP300—conduct disorder	0.0025	0.0025	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CGA—conduct disorder	0.00249	0.00249	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	0.00249	0.00249	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—WASF1—conduct disorder	0.00238	0.00238	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	0.00218	0.00218	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	0.00218	0.00218	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	0.00216	0.00216	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CGA—conduct disorder	0.0021	0.0021	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CGA—conduct disorder	0.00209	0.00209	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CGA—conduct disorder	0.00208	0.00208	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CGA—conduct disorder	0.00206	0.00206	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	0.00202	0.00202	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—DRD4—conduct disorder	0.00198	0.00198	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—DRD4—conduct disorder	0.00198	0.00198	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—DRD4—conduct disorder	0.00196	0.00196	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	0.00184	0.00184	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CGA—conduct disorder	0.00182	0.00182	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—WASF1—conduct disorder	0.00168	0.00168	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—WASF1—conduct disorder	0.00167	0.00167	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—DRD4—conduct disorder	0.00166	0.00166	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—WASF1—conduct disorder	0.00165	0.00165	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CGA—conduct disorder	0.00149	0.00149	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	0.00142	0.00142	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	0.00142	0.00142	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	0.00141	0.00141	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	0.00129	0.00129	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	0.00129	0.00129	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	0.00128	0.00128	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—DRD4—conduct disorder	0.00117	0.00117	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—DRD4—conduct disorder	0.00117	0.00117	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—DRD4—conduct disorder	0.00116	0.00116	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—COMT—conduct disorder	0.00113	0.00113	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—MAOA—conduct disorder	0.00112	0.00112	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HTR2A—conduct disorder	0.00109	0.00109	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CGA—conduct disorder	0.000975	0.000975	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—COMT—conduct disorder	0.000946	0.000946	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—MAOA—conduct disorder	0.00094	0.00094	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—COMT—conduct disorder	0.00082	0.00082	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—MAOA—conduct disorder	0.000814	0.000814	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000789	0.000789	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HTR2A—conduct disorder	0.000764	0.000764	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HTR2A—conduct disorder	0.000762	0.000762	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HTR2A—conduct disorder	0.000754	0.000754	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—COMT—conduct disorder	0.000673	0.000673	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—MAOA—conduct disorder	0.000668	0.000668	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EP300—conduct disorder	0.000575	0.000575	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—EP300—conduct disorder	0.000483	0.000483	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—COMT—conduct disorder	0.00044	0.00044	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—MAOA—conduct disorder	0.000437	0.000437	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—EP300—conduct disorder	0.000406	0.000406	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EP300—conduct disorder	0.000405	0.000405	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EP300—conduct disorder	0.000404	0.000404	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EP300—conduct disorder	0.0004	0.0004	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—EP300—conduct disorder	0.000352	0.000352	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—EP300—conduct disorder	0.000289	0.000289	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—EP300—conduct disorder	0.000189	0.000189	CbGpPWpGaD
